( en | de | ru )

 

Disambiguation of "Rolain, Jean-Marc"

Author of the publication

copydeleteadd this publication to your clipboard
Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world

, , , , , , , , , , , , , and . New Microbes and New Infections, (2020)
DOI: https://doi.org/10.1016/j.nmni.2020.100709

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jean-Marc Régis

Jean-Marc Chanton

Jean-Marc Schaller

Jean-Marc Leutenegger

Jean-Marc Montanier

 

Other publications of authors with the same name

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, , , and . International Journal of Antimicrobial Agents, 55 (5): 105938 (2020)Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, , , , , , and . Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 49 (4): 543--551 (August 2009)PMID: 19583519.Full-length title: NRPPUR database search and in vitro analysis identify an NRPS-PKS biosynthetic gene cluster with a potential antibiotic effect., , , , , and . BMC Bioinform., 19 (1): 463:1-463:10 (2018)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study, , , , , , , , , and 19 other author(s). Travel Medicine and Infectious Disease, (2020)This is the second Marseille study.Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world, , , , , , , , , and 4 other author(s). New Microbes and New Infections, (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , and 33 other author(s). Travel Medicine and Infectious Disease, (2020)Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier), , , , , , and . (2020)Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon., , , , , , , , , and . (June 2020)